Stifel Financial Corp. Stock News

ST. LOUIS, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for November 30, 2025, to provide timely information to investors on certain key performance metrics. Due to the limited nature of this data, a consistent correlation to earnings should not be assumed.

Stephen Glagola joins Keefe, Bruyette & Woods, a Stifel Company, as Managing Director and Senior Equity Research Analyst covering digital asset companies.

ST. LOUIS, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for October 31, 2025, to provide timely information to investors on certain key performance metrics. Due to the limited nature of this data, a consistent correlation to earnings should not be assumed.

Stifel Financial Corp. ( SF ) Wolfe Wealth Symposium 2026 November 13, 2025 1:15 PM EST Company Participants Ronald J. Kruszewski - Chairman & CEO James Marischen - Senior VP & CFO Conference Call Participants Steven Chubak - Wolfe Research, LLC Presentation Steven Chubak Wolfe Research, LLC Good afternoon to everybody in the room as well as those of you on the webcast.

The proposal by Smithson Investment Trust PLC (LSE:SSON) to roll into an open-ended fund, or offer a 100% cash exit alternative, could provide a template for other investment trusts trading at persistent discounts, according to Stifel.  Smithson, which has been dogged by its shares trading at a discount to net assets since 2022, proposed the scheme on Wednesday morning.

ST. LOUIS, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced its participation in the Wolfe Research Wealth Symposium on Thursday, November 13, 2025. Ron Kruszewski, Chairman and CEO, is scheduled to present at 1:15 p.m. Eastern time.

ST. LOUIS, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced that its Board of Directors has declared a cash dividend on shares of its common stock of $0.46 per share, payable December 15, 2025, to shareholders of record at the close of business on December 1, 2025. The Board of Directors also declared a quarterly cash dividend on the outstanding shares of its ...

BOSTON--(BUSINESS WIRE)--Seaport Therapeutics management team will present at Stifel 2025 Healthcare Conference on November 11 at 10:00AM EST.